All In Biotech

Drug Trial Radar · NCT07018635

A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

An Open-Label Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

Jul 16, 2025

Primary completion

Sep 29, 2025

Study completion Sep 29, 2025

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Jun 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.

Conditions

  • Healthy Participants

Interventions

  • INCB161734Drug

    Oral; Tablet

  • ItraconazoleDrug

    Oral; Tablet

  • RifampinDrug

    Oral; Tablet

  • EsomeprazoleDrug

    Oral; Tablet

  • FamotidineDrug

    Oral; Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics Parameter (PK): Cmax of INCB161734Time frame: Up to 2 months
  2. Pharmacokinetics Parameter: AUC(0-t) of INCB161734Time frame: Up to 2 months
  3. Pharmacokinetics Parameter: AUC 0-∞ of INCB161734Time frame: Up to 2 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.